PhilHealth covers MERS-CoV patients | Inquirer News

PhilHealth covers MERS-CoV patients

/ 05:51 AM February 27, 2015

MANILA, Philippines—The Philippine Health Insurance Corp. (PhilHealth) will be providing a benefits package for confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV).

Confirmed cases of MERS-CoV are those that have been tested at the Research Institute for Tropical Medicine (RITM), PhilHealth said.

PhilHealth members, whether health or nonhealth workers, may avail of the benefits in an accredited healthcare institution that has the capabilities and facilities to manage MERS-CoV, such as those with negative isolation rooms and respirators, the agency said.

ADVERTISEMENT

Under the benefits package, nonhealth workers will be provided up to a maximum of P50,000, while health workers can get as much as P100,000.

FEATURED STORIES

Nonhealth workers will be allocated a maximum of P10,000 (P1,500 per day) for room and board; P15,000 (P1,000 per day) for professional fees, and P25,000 for the medicines, laboratory tests, personal protective equipment and ambulance.

Health workers are entitled to a maximum P10,000 (P1,500 per day) for room and board; P30,000 (P1,000 per day) for professional fees, and P60,000 for medicines, laboratory tests, personal protective equipment and ambulance.

PhilHealth defines qualified “health workers” as those employees or institutional workers of a health care institution, whether located in the Philippines or abroad, that cared for, or had close contact with, a MERS-CoV patient and may have contracted the infection while performing such duty. Tina G. Santos

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: MERS-CoV, Philhealth, RITM

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.